A Case of Atypical Delayed and Prolonged Hematologic Toxicity With Azacitidine in Chronic Myelomonocytic Leukemia (CMML) and Review of Literature

Hypomethylating drugs are useful and have been approved for the treatment of myelodysplastic syndromes (MDS) and Chronic Myelomonocytic Leukemia (CMML). However, phase 2 and 3 studies that assessed these agents in MDS, have included only a small number of patients with CMML, and there are just a few...

Descripción completa

Detalles Bibliográficos
Autores principales: Elli, Elena, Cecchetti, Caterina, Belotti, Angelo, Borin, Lorenza, Pogliani, Enrico Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Università Cattolica del Sacro Cuore 2012
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3340986/
https://www.ncbi.nlm.nih.gov/pubmed/22550562
http://dx.doi.org/10.4084/MJHID.2012.017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3340986/
https://www.ncbi.nlm.nih.gov/pubmed/22550562
http://dx.doi.org/10.4084/MJHID.2012.017

Ejemplares similares